<Disease><Name>HYPERPHENYLALANINEMIA DUE TO DHPR-DEFICIENCY (DHPR)</Name><Synonym>PHENYLKETONURIA II; PKU II; DIHYDROPTERIDINE REDUCTASE DEFICIENCY; ATYPICAL PKU; DHPR</Synonym><OMIM><Number>261630</Number><URL>http://omim.org/entry/261630</URL></OMIM><Orphanet><Number>226</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=226</URL></Orphanet><Protein><Number>Dihydropteridine reductase</Number><URL>http://www.uniprot.org/uniprot/P09417</URL></Protein><ExPASy><Number>1.5.1.34</Number><URL>http://enzyme.expasy.org/EC/1.5.1.34</URL></ExPASy><Gene>4p15.31Detail information to gene locus by the National Center for Biotechnology Information NCBI:

Quinoid dihydropteridine reductase
</Gene><ICD>E70.1</ICD><Summary>rare (1:1000000) ;autosomal recessive ; mutation in the QDPR gene;BH4-Test</Summary><Symptoms><symtomp><id>2074</id><symptom>Amino acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2363</id><symptom>basal ganglia, changes, lesions, calcifications (MRI, CT)</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1945</id><symptom>chorea or athetosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1961</id><symptom>cortical or cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2117</id><symptom>CT, brain, abnormalities [-] / CT, kraniell, abnormal </symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>4063</id><symptom>decreased hair pigmentation (hypopigmented)</symptom><category>SKIN</category></symtomp><symtomp><id>3982</id><symptom>drooling</symptom><category>HEAD</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>4042</id><symptom>EEG, spike waves [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2631</id><symptom>hypersalivation</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>2537</id><symptom>hyperthermia</symptom><category>ENDOCRINE SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2268</id><symptom>pigmentation, skin and sclera</symptom><category>SKIN</category></symtomp><symtomp><id>2273</id><symptom>pneumonia</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1919</id><symptom>progressive neurologic defect</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>4041</id><symptom>seizures, myoclonic</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3343</id><symptom>skin rash, eczematous or seborrhoic / skin rash</symptom><category>SKIN</category></symtomp><symtomp><id>3315</id><symptom>temperature instability</symptom><category>GENERAL TOPICS | GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1624</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>1.80</min><max>12.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1652</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>3.50</min><max>11.20</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1781</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>120.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1837</id><name>Neopterin</name><specimen>urine</specimen><value>normal</value><min>0.00</min><max>17.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1961</id><name>Phenylalanine</name><specimen>blood</specimen><value>normal</value><min>0.00</min><max>120.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1962</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>34.00</min><max>86.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>2089</id><name>Biopterin</name><specimen>urine</specimen><value>normal/inc</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>2090</id><name>Biopterin</name><specimen>urine</specimen><value>normal/inc</value><min>0.50</min><max>2.70</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2140</id><name>Prolactin</name><specimen>serum</specimen><value>normal/inc</value><min>4.79</min><max>23.30</max><unit>ng/ml</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1387</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>910</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>120.00</min><max>500.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>931</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>105.00</min><max>299.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1001</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>    </min><max>11.50</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1388</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>0.20</min><max>8.70</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>424</id><name>Biopterin</name><specimen>urine</specimen><value>normal/inc</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>425</id><name>Biopterin</name><specimen>urine</specimen><value>normal/inc</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>426</id><name>Biopterin</name><specimen>urine</specimen><value>normal/inc</value><min>0.50</min><max>2.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>934</id><name>Biopterin</name><specimen>cerebrospinal fluid</specimen><value>normal/inc</value><min>10.00</min><max>50.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>790</id><name>Dihydropteridin reductase</name><specimen>erythrocytes</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>938</id><name>Dihydropteridin reductase</name><specimen>liver</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>939</id><name>Dihydropteridin reductase</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>940</id><name>Dihydropteridin reductase</name><specimen>leucocytes</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>684</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>3.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>685</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>686</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>6.00</min><max>42.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>687</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>1.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>688</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>1.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2022</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>911</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>normal/dec</value><min>100.00</min><max>900.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>932</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>normal/dec</value><min>211.00</min><max>871.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1919</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>422</id><name>Neopterin</name><specimen>urine</specimen><value>normal</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1054</id><name>Neopterin</name><specimen>urine</specimen><value>normal</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>423</id><name>Neopterin</name><specimen>urine</specimen><value>normal</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>427</id><name>Neopterin</name><specimen>urine</specimen><value>normal</value><min>0.20</min><max>1.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>935</id><name>Neopterin</name><specimen>cerebrospinal fluid</specimen><value>normal</value><min>9.00</min><max>20.00</max><unit>nmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1055</id><name>Neopterin</name><specimen>cerebrospinal fluid</specimen><value>normal</value><min>9.00</min><max>40.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>1548</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>156</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>4.00</min><max>32.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>871</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>31.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1513</id><name>Phenylalanine</name><specimen>urine</specimen><value>increased</value><min>7.00</min><max>28.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>52</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>21.00</min><max>137.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>930</id><name>Phenylalanine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>20.00</max><unit>&#956;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1057</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>35.00</min><max>85.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1294</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>26.00</min><max>85.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1295</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>26.00</min><max>98.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite></Metabolites><Literatures><literature><id>7586</id><title>Genome sequencing identifies a homozygous inversion disrupting QDPR as a cause for dihydropteridine reductase deficiency</title><author>Lillev&#228;li H,</author><journal>Mol Genet Genomic Med</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages>e1154</pages><co_aut>et al.</co_aut></literature><literature><id>7585</id><title>Dihydropteridine Reductase Deficiency: A Treatable Neurotransmitter Movement Disorder Masquerading as Refractory Epilepsy Due t</title><author>Gowda VK;</author><journal>Indian J Pediatr</journal><year>2018</year><book /><volume>85</volume><number>9</number><pages>812-813</pages><co_aut>et al.</co_aut></literature><literature><id>7587</id><title>Malignant Phenylketonuria (PKU) Due to Dihydropteridine Reductase (DHPR) Deficiency</title><author>Ventzke A,</author><journal>Ir Med J</journal><year>2015</year><book /><volume>108</volume><number>10</number><pages>312-314</pages><co_aut>et al.</co_aut></literature><literature><id>7588</id><title>Molecular Characterization of QDPR Gene in Iranian Families with BH4 Deficiency: Reporting Novel and Recurrent Mutations</title><author>Foroozani H,</author><journal>JIMD Rep</journal><year>2015</year><book /><volume>21</volume><number>0</number><pages>123-128</pages><co_aut>et al.</co_aut></literature><literature><id>7589</id><title>QDPR gene mutation and clinical follow-up in Chinese patients with dihydropteridine reductase deficiency</title><author>Lu DY,</author><journal>World J Pediatr</journal><year>2014</year><book /><volume>10</volume><number>3</number><pages>1219-226</pages><co_aut>et al.</co_aut></literature><literature><id>2784</id><title>Serum prolactin as a tool for the follow-up of treated DHPR-deficient patients</title><author>Concolino D</author><journal>J Inherit Metab Dis</journal><year>2008</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2785</id><title>Click here to read Links     Dihydropteridine reductase deficiency: levodopas long-term effectiveness without dyskinesia</title><author>Sedel F</author><journal>Neurology</journal><year>2006</year><book /><volume>67</volume><number>12</number><pages>2243-2245</pages><co_aut>et al.</co_aut></literature><literature><id>2428</id><title>Dihydropteridine reductase deficiency in man: from biology to treatment</title><author>Ponzone A</author><journal>Med Res Rev</journal><year>2004</year><book /><volume>24</volume><number>2</number><pages>127-150</pages><co_aut>et al.</co_aut></literature><literature><id>2427</id><title>Molecular analysis of 16 Turkish families with DHPR deficiency using denaturing gradient gel electrophoresis (DGGE)</title><author>Romstad A</author><journal>Hum Genet</journal><year>2000</year><book /><volume>107</volume><number>6</number><pages>546-553</pages><co_aut>et al.</co_aut></literature><literature><id>365</id><title>International database of tetrahydrobiopterin deficiencies</title><author>Blau N</author><journal>J Inherit Metab Dis</journal><year>1996</year><book /><volume>19</volume><number>0</number><pages>8-14</pages><co_aut>Barnes I, Dhondt JL</co_aut></literature><literature><id>1008</id><title>Hyperphenylalaninemia</title><author>Blau N</author><journal>in Blau N, Duran M, Blaskovics E (eds): in Physicians guide to the laboratory diagnosis of metabolic diseases; Chapman and Hall, London</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>65-78</pages><co_aut>Blaskovics ME</co_aut></literature><literature><id>113</id><title>The hyperphenylalaninemias</title><author>Scriver CR</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>0</number><pages>1015-1075</pages><co_aut>et al.</co_aut></literature><literature><id>260</id><title>Molecular basis of dihydropteridine reductase deficiency</title><author>Smooker PM</author><journal>Hum Mutat</journal><year>1995</year><book /><volume>5</volume><number>4</number><pages>279-284</pages><co_aut>Cotton RG</co_aut></literature><literature><id>877</id><title>Monoaminergic effects of folinic acid, L-DOPA, and 5-hydroxytryptophan in dihydropteridine reductase deficiency</title><author>Goldstein DS</author><journal>J Neurochem</journal><year>1995</year><book /><volume>64</volume><number>0</number><pages>2810-2813</pages><co_aut>et al.</co_aut></literature><literature><id>262</id><title>Tetrahydrobiopterin deficiency and an international database of patients</title><author>Blau N</author><journal>Adv Exp Med Biol</journal><year>1993</year><book /><volume>338</volume><number>0</number><pages>255-261</pages><co_aut>Dhondt JN</co_aut></literature><literature><id>279</id><title>Hyperphenylalaninaemia due to tetrahydrobiopterin deficiency: a report of 16 cases</title><author>Coskun T</author><journal>J Inherit Metab Dis</journal><year>1993</year><book /><volume>16</volume><number>3</number><pages>605-607</pages><co_aut>et al.</co_aut></literature><literature><id>876</id><title>Catalytic activity of tetrahydrobiopterin in dihydropteridine reductase deficiency and indications for treatment</title><author>Panzone A</author><journal>Pediatr Res</journal><year>1993</year><book /><volume>33</volume><number>0</number><pages>125-128</pages><co_aut>et al.</co_aut></literature><literature><id>278</id><title>Strategy for the screening of tetrahydrobiopterin deficiency among hyperphenylalaniaemic patients: 15-years experience</title><author>Dhondt JL</author><journal>J Inherit Metab Dis</journal><year>1991</year><book /><volume>14</volume><number>2</number><pages>117-127</pages><co_aut /></literature></Literatures></Disease>